DEVICE REVIEW SHIELDING FROM S 830 IMPLEMENTATION BURDENS TO BE FOCUS OF INDUSTRY REPS AT MEETING WITH AGENCY; FDA COMMISSIONER WATCH FOCUSES ON HENNEY
This article was originally published in The Gray Sheet
Executive Summary
Ensuring that implementation of the FDA reform bill signed into law Nov. 21 does not slow down premarket device reviews will be one of the priorities underscored by industry participants at a Nov. 24 implementation task force meeting with Center for Devices and Radiological Health staffers, industry reps say.